Five things to know:
1. In 2017, XLIF interbody cages dominated the market with 75.8 percent of the market share.
2. The U.S. held the largest market share at 73.3 percent in 2017. The U.S. is predicted to remain dominant.
3. Based on end user, hospitals are expected to dominate the XLIF market through 2024.
4. Major factors driving the market’s growth include the rising number of minimally invasive procedures, increasing number of spinal disorders and growing geriatric population.
5. Key market players to dominate include NuVasive, RTI Surgical, K2M, Johnson & Johnson, Titan Spine and Zimmer Biomet.
More articles on devices and implants:
2 Qs with OSSIO CEO Brian Verrier
DePuy Synthes creates new jobs in Ireland with investment: 3 details
Zimmer Biomet receives FDA approval for robotically-assisted knee system: 3 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.